MENU
+Compare
ARAY
Stock ticker: NASDAQ
AS OF
Apr 14 closing price
Price
$1.51
Change
+$0.05 (+3.42%)
Capitalization
244.95M

ARAY Accuray Forecast, Technical & Fundamental Analysis

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives... Show more

ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ARAY with price predictions
Apr 11, 2025

ARAY's Stochastic Oscillator sits in oversold zone for 8 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARAY advanced for three days, in of 256 cases, the price rose further within the following month. The odds of a continued upward trend are .

ARAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ARAY as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ARAY turned negative on April 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARAY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ARAY entered a downward trend on April 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.015) is normal, around the industry mean (23.907). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.519) is also within normal values, averaging (42.115).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ARAY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ARAY is expected to report earnings to fall 274.50% to -3 cents per share on April 29

Accuray ARAY Stock Earnings Reports
Q1'25
Est.
$-0.03
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.01
Q2'24
Est.
$0.03
Q1'24
Missed
by $0.05
The last earnings report on February 05 showed earnings per share of 1 cents, beating the estimate of -2 cents. With 678.09K shares outstanding, the current market capitalization sits at 244.95M.
A.I. Advisor
published General Information

General Information

a manufacturer of medical equipment

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1240 Deming Way
Phone
+1 608 824-2800
Employees
1024
Web
https://www.accuray.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.401.38
+5.52%
GameStop Corp
AAPL198.157.73
+4.06%
Apple
SPY533.949.36
+1.78%
SPDR® S&P 500® ETF
TSLA252.31-0.09
-0.04%
Tesla
BTC.X83684.980000-1602.132800
-1.88%
Bitcoin cryptocurrency

ARAY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with IQV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
-1.35%
IQV - ARAY
44%
Loosely correlated
+1.63%
ALGN - ARAY
37%
Loosely correlated
+2.50%
VREX - ARAY
36%
Loosely correlated
N/A
ATRC - ARAY
36%
Loosely correlated
+1.36%
NVST - ARAY
36%
Loosely correlated
-0.51%
More